12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-27), ICU Medical's 12-1 Month Momentum % is -44.38%.
The industry rank for ICU Medical's 12-1 Month Momentum % or its related term are showing as below:
ICUI's 12-1 Month Momentum % is ranked worse than 77.4% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: -17.465
vs ICUI: -44.38
Competitive Comparison of ICU Medical's 12-1 Month Momentum %
For the Medical Instruments & Supplies subindustry, ICU Medical's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical's 12-1 Month Momentum % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where ICU Medical's 12-1 Month Momentum % falls into.
ICU Medical (NAS:ICUI) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical (NAS:ICUI) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
ICU Medical 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of ICU Medical's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017, and Smiths Medical from Smiths Group in 2022. It holds top-tier positions in its original reporting segments: infusion consumables (25% of 2022 revenue), IV solutions (16%), infusion systems (15%), and critical care (2%) as well as its new Smiths segments: Smiths infusion systems (15%), vascular access (14%), and vital care (12%). The combined entity remains primarily U.S. focused, generating over 64% of its sales domestically.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ICUI has been successfully added to your